ClinVar Genomic variation as it relates to human health
NM_033629.6(TREX1):c.850dup (p.Arg284fs)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_033629.6(TREX1):c.850dup (p.Arg284fs)
Variation ID: 3376804 Accession: VCV003376804.1
- Type and length
-
Duplication, 1 bp
- Location
-
Cytogenetic: 3p21.31 3: 48467504-48467505 (GRCh38) [ NCBI UCSC ] 3: 48508903-48508904 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Nov 25, 2024 Nov 24, 2024 Dec 21, 2023 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_033629.6:c.850dup MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_338599.1:p.Arg284fs frameshift NM_130384.3:c.*1951dup MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
3 prime UTR NM_001271022.2:c.*1951dup 3 prime UTR NM_001271023.2:c.*1951dup 3 prime UTR NM_007248.5:c.820dup NP_009179.2:p.Arg274fs frameshift NM_032166.4:c.*1951dup 3 prime UTR NM_033629.4:c.850dupA frameshift NR_153405.1:n.4159dup non-coding transcript variant NC_000003.12:g.48467505dup NC_000003.11:g.48508904dup NG_009820.2:g.6676dup NG_033100.1:g.38356dup NG_033100.2:g.42305dup NG_041782.1:g.25796dup NG_099340.1:g.566dup LRG_282:g.6676dup LRG_282t1:c.850dup LRG_282p1:p.Arg284fs - Protein change
- R274fs, R284fs
- Other names
- -
- Canonical SPDI
- NC_000003.12:48467504:A:AA
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
ATRIP | - | - |
GRCh38 GRCh37 |
1 | 789 | |
ATRIP-TREX1 | - | - | - | GRCh38 | - | 773 |
TREX1 | - | - |
GRCh38 GRCh37 |
4 | 540 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Likely pathogenic (1) |
criteria provided, single submitter
|
Dec 21, 2023 | RCV004788418.1 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Likely pathogenic
(Dec 21, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations
(Autosomal dominant inheritance)
Affected status: yes
Allele origin:
germline
|
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute
Additional submitter:
Shariant Australia, Australian Genomics
Accession: SCV005400297.1
First in ClinVar: Nov 24, 2024 Last updated: Nov 24, 2024 |
Comment:
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Likely Pathogenic. Following criteria are met: 0103 - Dominant negative and loss of function … (more)
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Likely Pathogenic. Following criteria are met: 0103 - Dominant negative and loss of function are known mechanisms of disease in this gene and are associated with TREX1-related conditions. Loss of function is generally associated with recessive disease, while dominant negative variants are associated with dominant disease (OMIM, PMID: 21937424). However, loss of function is the mechanism of disease associated with heterozygous C-terminal frameshift variants identified in individuals with vasculopathy, retinal, with cerebral leukoencephalopathy and systemic manifestations (MIM#192315) (OMIM). (I) 0108 - This gene is known to be associated with both recessive and dominant disease. Aicardi-Goutieres syndrome is predominantly a recessive condition; however, there have been rare cases of a dominant form of the disease reported (OMIM). (I) 0115 - Variants in this gene are known to have variable expressivity, with intrafamilial and interfamilial variability reported (PMID: 33516249). (I) 0208 - Variant is predicted to result in an elongated protein. (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0309 - A downstream protein elongation change has been observed in gnomAD (v2) (4 heterozygotes, 0 homozygotes). (I) 0600 - Variant affects the annotated putative transmembrane helix (PMID: 27604306). Functional studies have shown the C-terminal region contains a perinuclear localization signal. However, the exact location of this signal and if this variant affects it, is unclear (PMID: 17660820). (I) 0704 - Other protein elongation variants comparable to the one identified in this case have limited previous evidence for pathogenicity. Two of these variants have been reported as likely pathogenic or pathogenic (ClinVar), and observed in families with hereditary endotheliopathy with retinopathy, nephropathy, and stroke (HERNS) (PMID: 17660820). Other further downstream elongation variants have been reported as VUS (ClinVar), and in a compound heterozygous individual with epilepsy (PMID: 29720203). (SP) 0803 - This variant has limited previous evidence of pathogenicity in an unrelated individual. This variant was observed in a single family with HERNS (PMID: 17660820; PMID: 27604306). (SP) 0906 - Segregation evidence for this variant is inconclusive. This variant has segregated with disease in three individuals from the same family; however, this is an insufficient number of meioses to establish pathogenicity (PMID: 17660820; PMID: 27604306). (I) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
High clinical heterogeneity in a Chinese pedigree of retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S). | Xie N | Orphanet journal of rare diseases | 2021 | PMID: 33516249 |
Detection rate of causal variants in severe childhood epilepsy is highest in patients with seizure onset within the first four weeks of life. | Staněk D | Orphanet journal of rare diseases | 2018 | PMID: 29720203 |
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations. | Stam AH | Brain : a journal of neurology | 2016 | PMID: 27604306 |
The TREX1 exonuclease R114H mutation in Aicardi-Goutières syndrome and lupus reveals dimeric structure requirements for DNA degradation activity. | Orebaugh CD | The Journal of biological chemistry | 2011 | PMID: 21937424 |
C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. | Richards A | Nature genetics | 2007 | PMID: 17660820 |
Text-mined citations for this variant ...
HelpRecord last updated Nov 30, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.